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Abstract— Goal: Maintaining a constant contact force of an 
ablation catheter during cardiac catheter ablation therapy is 
clinically challenging due to inherent myocardial motion, often 
resulting in poor ablation of arrhythmogenic substrates. To 
enable a prescribed contact force to be applied during ablation, a 
catheter contact force controller (CCFC) was developed. 
Methods: The system includes a hand-held device attached to a 
commercial catheter and steerable sheath. A compact linear 
motor assembly attaches to an ablation catheter and 
autonomously controls its relative position within the shaft of the 
steerable sheath. A closed-loop control system is implemented 
within embedded electronics to enable real-time catheter-tissue 
contact force control. To evaluate the performance of the CCFC, 
a linear motion phantom was used to impose a series of 
physiological contact force profiles; lesion contact force was 
controlled at prescribed levels ranging from 15 to 40 g.  Results: 
For a prescribed contact force of 25 g, the CCFC was able to 
regulate the contact force with a root mean squared error of 3.7 ± 
0.7 g. The ability of the CCFC to retract the catheter upon 
sudden changes in tissue motion, which may have caused tissue 
damage, was also demonstrated. Finally, the device was able to 
regulate the contact force for a predetermined amount of time 
according to a force-time integral model. Conclusion: The 
developed CCFC is capable of regulating catheter-tissue contact 
force in a laboratory setting that mimics clinical ablation 
therapy. Significance: Catheter-tissue contact force control 
promises to improve the precision and success of ablation lesion 
delivery. 
 
Index Terms—Catheterization, force control, linear actuators, 
real-time systems, medical robotics, robot manipulators.  
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I. INTRODUCTION 
ercutaneous radiofrequency (RF) catheter ablation is 
becoming the standard of care for a variety of cardiac 
arrhythmias. Cardiac interventionalists introduce ablation 
catheters into the heart and manipulate them until the distal tip 
contacts the targeted myocardium. Once reached, RF power is 
delivered to form ablation lesions that interrupt the electrical 
pathways responsible for the arrhythmia. For successful 
treatment it is important that these lesions are transmural, as 
superficial lesions leave areas of healthy myocardium that 
may result in conduction recurrence and ablation failure.  
Catheter-tip-to-tissue contact force (CF) has been shown to 
be an indicator for assessing lesion development [1-5], and CF 
guidelines have been established to label a delivered lesion as 
effective [6-8]. Additional studies have shown that monitoring 
both the duration of the delivery and CF at a specific RF 
power can predict lesion volume [3, 6-11]. Conventionally 
described as a Force-Time Integral (FTI), the model may be 
used as a prospective quantitative tool to determine lesion 
volume under defined parameters. Unfortunately, this model is 
dependent on catheter stability and while used in the clinic as 
a guide, it has not been used as a quantitative metric that can 
predict lesion volume or transmurality. Finally, lesions 
delivered with excessive CF present a risk of deep tissue 
overheating, which may result in “steam pop”, perforation and 
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Fig. 1. Modern electromagnetic catheter tracking systems (e.g. CARTO, 
Biosense Webster Ltd., Yokneam, Israel) enable visual feedback of the real-
time CF experienced on the tip of the catheter (e.g. 7.5F SmartTouch, 
Biosense Webster Ltd., Diamond Bar, CA, USA). The figure is a snapshot 
demonstrating catheter location in the rendered left atrium (white with green 
tip) and the CF as a function of time in the lower right hand corner.  Note the 
variation in CF with cardiac and respiratory motion. Image courtesy of 
London Health Science Center.  
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injury outside the heart, including esophageal, pulmonary and 
phrenic nerve damage [2]. These potential risks often inhibit 
the interventionalist and cause them to deliver the lesion 
tentatively, with a lower level of CF to lessen the risk of 
injury. Clinically, CF information is often used as a guide to 
ensure catheter tip contact and confine the CF within 
acceptable ranges, but is ultimately limited by tissue motion, 
as seen in the CF profile in the lower right-hand corner of Fig. 
1.  
While ideally the CF should be regulated within a 
prescribed range, interventionalists cannot respond fast 
enough to compensate for cardiac and respiratory motion [12]. 
Approaches to minimize myocardial motion during ablation, 
have been proposed, including high-frequency-jet ventilation 
[13]. None have successfully provided a motionless 
environment in all patients [14]. Kesner et al. [15] 
demonstrated CF control of catheters and instruments used for 
mitral valve repair, however, the implementation does not 
address problems associated with catheter ablation.  
Commercial force-sensing ablation catheters enable the 
interventionalist to simultaneously monitor the CF in real-time 
while delivering the lesion, as illustrated in Fig. 1. Often these 
catheters are used together with steerable sheaths, whose 
added level of versatility and stability has increased clinical 
success [13, 16, 17]. The interventionalist typically 
manipulates the steerable sheath until the catheter is pointing 
at the target region, and then advances the catheter forward 
through the sheath until the desired level of CF is imparted 
onto the tissue. 
In this manuscript, we introduce a tool that enables the 
delivery of effective RF lesions by autonomously regulating 
the CF of a force-sensing ablation catheter based only on the 
real-time CF measurements. The Catheter Contact-Force 
Controller (CCFC) is a hand-held, modular device that enables 
robotic control of the catheter within the sheath, which 
otherwise would be done manually by the interventionalist. 
The CCFC is an add-on tool compatible with commercially 
available, preexisting force-sensing ablation catheters and 
sheaths. 
II. SYSTEM DESCRIPTION 
Incorporation of the CCFC replaces the manual 
manipulation of the catheter through the sheath. Rather than 
advancing the catheter forward until a sufficient CF level is 
reached, the interventionalist would engage the CCFC, which 
monitors the CF in real-time and updates the position of the 
catheter to maintain the CF experienced at the tip of the 
catheter at a desired level, despite motion of the target tissue. 
The CCFC system comprises a hand-held, compact, 
electromechanical device and an embedded system.  
A. Hand-Held Device 
The hand-held CCFC device, Fig. 2, is mechanically 
clamped to the distal end of the sheath handle (i.e. at the 
hemostatic seal and insertion point of the catheter). A catheter-
locking adapter rigidly clamps the catheter shaft onto a 
precision linear actuator (LM2070-040, MICROMO, 
Clearwater, USA) traveling along a 12 mm diameter 134 mm 
long precision magnetic shaft. Movement of the actuator 
directly translates to movement of the catheter through the 
sheath. The adapter and actuator are mounted within an 
enclosure, which is designed to securely lock onto the sheath 
handle, while keeping the catheter concentrically mounted 
within the hemostatic seal. A set of hinges and latches enables 
easy clamping and removal of the CCFC. Both the adapter and 
enclosure were fabricated in polypropylene using additive 
manufacturing (Objet3D Pro, Stratasys Ltd., Rehovot, Israel). 
B. Hybrid Control System 
To maintain a prescribed CF between the tip of the catheter 
and a moving target we implemented a hybrid control system. 
Common closed-loop proportional-integral-derivative (PID) 
control algorithms are based on minimizing the error between 
the desired and actual inputs, and have been shown to be a 
viable solution in robotic catheter control systems [15, 18-20]. 
The CCFC uses a hybrid PID controller, a slight variation of a 
standard PID controller, whose control parameters change 
based on the error argument. The control signal u(t) is 
calculated as: 
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where the error e(t) is the difference between the desired 
and current contact forces, FD and FC(t) respectively. The 
control parameters KP, KI and KD generate a different control 
signal depending on the error measured in real time. If the 
error is larger than a predefined CF threshold, FT, the control 
system is in an “aggressive” state indicated by KPA, KIA, KDA. 
When the error is lower than FT the control system operates in 
a “conservative” state indicated by KPC, KIC, KDC. The CF 
threshold was empirically assigned to be 5g – a level that was 
observed to retain steady-state accuracy. 
 
Fig. 2 Schematic side-view (a) and photograph top-view (b) of the 
electromechanical hand-held CCFC attached to a steerable sheath and force-
sensing ablation catheter. Movement of the linear actuator along the fixed 
magnetic rod moves the catheter through the hemostatic seal of the sheath 
handle. 
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Tuning of the aggressive control parameters was achieved 
using the Tyrues-Luyben tuning method, as implemented by 
[21]. The conservative control parameters were manually 
tuned for a desired steady-state response; in the current 
implementation, the conservative control parameters were at 
least a factor of 4 smaller than the aggressive ones. 
C. Electronic Hardware Design 
The hybrid control system was implemented within an 
embedded electronic system, enabling real-time control of the 
linear actuator. A microcontroller development platform based 
on a Atmel SAM3X8E 84 MHz 32-bit ARM architecture 
(Due, Arduino LLC, Ivrea, Italy) generates a pulse-width 
modulated (PWM) control signal, based on the measured and 
desired contact force, which acts as input to the linear actuator 
controller and driver circuitry (MCLM-3003, MICROMO, 
Clearwater, USA). This daughter board is programmed with a 
native velocity proportional-integral (PI) controller that 
controls the speed of the motor based on the input PWM 
signal. Tuning of the PI controller was performed using the 
manufacturer’s tuning software, before tuning the hybrid PID 
system. The update rate of the hybrid PID system was set to 
1 kHz, which was the maximum rate of the linear actuator 
controller. Figure 3 is a block diagram of the designed 
embedded system. 
D. Linear Motion Phantom 
To evaluate the CCFC’s ability to regulate CF on a moving 
target in vitro, a custom built linear motion phantom was 
developed (Fig. 4). The motion phantom was built to provide 
sinusoidal and physiologic motion profiles. A gear motor with 
a Hall effect encoder (37D Gearmotor, Pololu Electronics, Las 
Vegas, NV, USA) drives a lead screw mechanism providing 
linear motion to a carriage. A second PID control system 
within an embedded electronic system controls the motion 
stage: the circuit board assembly includes a microcontroller 
development platform (Due, Arduino LLC, Ivrea, Italy) and a 
DC motor driver daughter board (VNH5019 Driver Shield, 
Pololu Electronics, Las Vegas, NV, USA). A strain gauge 
capable of detecting force with 200-milligram resolution 
(S100, Strain Measurement Devices, Wallingford, CT, USA), 
coupled to a linear amplifier (CSG110, FUTEK Inc., Irvine, 
CA, USA), is mounted on the carriage and used to measure the 
CF of the tip of the catheter. A piece of silicone (Dragon Skin 
30, Smooth-On Inc., Macungie, PA, USA) is positioned 
between the strain gauge and the tip of the catheter to mimic 
soft tissue compliance. A setscrew fixes the sheath firmly in 
place without hindering movement of the catheter housed 
within the sheath. Linear calibration, according to Hooke’s 
law, was first performed to determine the relationship between 
the displacement of the tissue and the force measured by the 
strain gauge. 
The phantom was programmed to execute arbitrary 
sinusoidal and sine-sweep motion profiles and to replicate 
physiological motion. Contact force profiles were recorded by 
force-sensing ablation catheters during typical ablation 
procedures, similar to the profile illustrated in Fig. 1. These 
profiles, containing both high-frequency low-amplitude 
cardiac and low-frequency high-amplitude respiratory motion, 
were programmed into the motion phantom as position 
trajectories, using the linear calibration parameters.  
The signal from the strain gauge, measured in real time, was 
used as the CF feedback signal of the CCFC control system 
(Fig. 3) and represent a surrogate of the CF signal that would 
be provided by a commercial force-sensing catheter. 
III. SYSTEM EVALUATION 
A. Linear Motion Phantom Evaluation 
The linear motion phantom was first evaluated to ensure 
that the executed motion profiles mimic the physiological 
motion that results in contact force profiles similar to those 
measured clinically. The catheter was held fixed while the 
linear motion phantom imposed 16 different patient-specific 
motion profiles. The sheath was locked in place for half of the 
experiments. The real-time CF measurements provided by the 
strain gauge were recorded and compared to the corresponding 
CF profiles. No attempt was made to perfectly match the 
executed CF profiles to the corresponding patient profiles and 
the measured CF profiles were only inspected visually, 
ensuring the range of amplitudes and frequencies were within 
the physiologic range.   
 
B. Catheter Contact-Force Controller Evaluation 
Experiments were performed to evaluate the overall 
accuracy and dynamic performance of the CCFC. For these 
experiments, the CCFC was attached to the rear end of a 
commonly used steerable sheath (8F Agilis NxT, St. Jude 
Medical, Saint Paul, MN, USA) and CF sensing ablation 
catheter (7.5F SmartTouch, Biosense Webster Ltd., Diamond 
Bar, CA, USA) combination. Water was introduced via the 
sheath’s side port to mimic the clinical setting and reduce the 
friction between the sheath and catheter. The sheath and 
catheter were inserted into the linear motion phantom as 
illustrated in Fig. 5.  
 
Fig. 3. Block diagram of the embedded system controlling the CCFC.  
 
Fig. 4. Linear motion phantom with the catheter and sheath loaded, used to 
evaluate the CCFC. The linear motion imposed on the tip of the catheter 
simulates myocardial tissue motion.  
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1) Step Response: The response of the CCFC control 
system to a step input (of 25 g) was first evaluated. The step 
response was then measured during 25 repeats and the rise 
time, overshoot, and peak level were characterized. During 
these experiments, the linear motion phantom was kept fixed.  
2) Safety: It is important to ensure that the CCFC can 
respond to excessive, fast and sudden motions that may result 
in tissue perforation. The linear motion phantom was 
programmed to impose a bidirectional continuous sine sweep 
motion profile, sweeping from 0.1 Hz to 2.5 Hz with 
amplitude of 70 g peak-to-peak. This unlikely clinical scenario 
was selected following Fourier analysis of over 40 patient-
specific CF profiles and determining that the maximum 
frequency component observed was 2.5 Hz. While the 
phantom executed the prescribed motion, the CCFC was 
engaged and attempted to regulate the CF to a desired 
reference of 25 g. The maximum error between the desired 
and actual contact force was measured. This experiment was 
repeated 10 times.  
3) Patient-Specific Dynamic Response: To evaluate the 
overall performance of the CCFC versus manual intervention, 
the linear motion phantom was programed to execute 16 
different patient motion profiles. Prior to any evaluation of the 
CCFC, a control experiment was performed whereby the 
phantom replicated each profile with the CCFC’s disabled. 
This is representative of manual intervention, where the 
interventionalist contacts the catheter to moving myocardial 
tissue and holds the catheter still to deliver a lesion. The 
experiment was then repeated with the CCFC programmed to 
deliver 15 g, 25 g, and 40 g for the duration of the motion 
profile. Statistical analysis of the regulated CF profiles was 
performed to calculate mean, confidence interval, and root-
mean-squared error (RMSE). Histograms of CF were also 
plotted for the “manual” and CCFC interventions. Note that 
for this study we use the term “manual” to refer to the CF 
profile representative of CF profiles recorded during clinical 
ablation procedures. 
4) Force-Time Integral: This experiment was designed to 
demonstrate that the CCFC could be used not only to regulate 
the delivered force, but also to deliver lesions with prescribed 
FTI.  The CCFC was programmed to deliver a prescribed FTI 
at a desired CF while the linear motion phantom imposed a 
patient motion profile. For each FTI/CF combination an 
expected duration can be calculated. The CCFC was 
programmed to calculate the FTI, and automatically retract the 
tip of the catheter back into the sheath once the desired FTI 
was reached. The generated CF profile and duration of 
catheter engagement was recorded and compared with 
expected values. This experiment was then repeated for 
various configurations of FTI and CF, which may be user-
defined in a clinical setting. The tested FTI values were 500, 
1000, and 1500 gs, where each was repeated with 25 and 40 g 
of CF. Each configuration was repeated 3 times.  
IV. RESULTS 
A. Linear Motion Phantom 
The linear motion phantom was able to replicate a range of 
patient-specific CF profiles. The profiles chosen to evaluate 
the CCFC are characteristic of typical cardiorespiratory 
patterns depicted in Fig. 6(a) as well as irregular profiles 
associated with patient motion or catheter instability depicted 
in Fig. 6(c). The generated CF curves, shown in Fig. 6(b, d), 
visually demonstrate a high level of similarity to the 
corresponding clinically acquired profiles (Fig. 6 a and c).  
These results demonstrate that the linear motion phantom is 
able to replicate cardiorespiratory forces that is typically 
encountered during catheter RF delivery and is appropriate to 
be used as a phantom for the CCFC’s evaluation. Locking the 
sheath in place did not affect the results. 
B. CCFC – Step Response 
The response of the CCFC’s control system to a 25 g step 
input is shown in Fig. 7. The following step response 
characteristics were calculated from the measurements: 
38 ± 3 ms rise time, 3 ± 2 g overshoot, and peak of 29 ± 2 g; 
means and standard deviations of 25 repeats of the step 
response are reported. The negligible overshoot and oscillation 
indicate that the tuning method used to determine the control 
Fig. 6. Two representative patient CF profiles ((a) and (c)) and the   
corresponding CF profiles ((b) and (d), respectively) imposed on a fixed 
catheter tip by the linear motion phantom, executing the same patient profile. 
The motion profiles depicted in (b) and (d) are profile #13 and #3 in Fig. 8(d), 
respectively. 
 
Fig. 5. Experimental setup to used to evaluate the performance of the CCFC. 
(a) line drawing (not to scale) showing the CCFC, sheath and catheter 
mounted with the linear motion phantom (b); photographs of the CCFC (c) 
and motion phantom (d) are also shown. 
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parameters has resulted in a desired transient and steady state 
response. 
C. CCFC – Safety 
During the control of a 70 g peak-to-peak sine sweep from 
0.1 Hz to 2.5 Hz, the maximum difference between the 
prescribed and measured CF was 15 ± 2 g, with all measured 
CF values being below 42 g. These results demonstrate that 
the CCFC is capable of reacting to sudden changes of tissue 
displacement that would otherwise result in large spikes of CF 
and potentially cause tissue damage.  
D. CCFC – Patient-Specific Dynamic Response 
The CCFC was able to significantly transform the CF 
profile on the catheter tip in comparison to manual 
intervention (p<0.001). Figure 8(a-c) depicts the distribution 
of measured CF for three motion profiles, representative of 
CFs measured during the delivery of different lesions; 
histograms are plotted for both manual and CCFC-controlled 
interventions, with a prescribed CF level of 25 g. The images 
in Fig. 8(d, manual) and Fig. 8(e, CCFC-controlled) are grey-
scale representations of the CF histograms for all 16 motion 
profiles; they clearly demonstrate that when the CCFC is 
engaged the prescribed mean force is achieved for all motion 
profiles.  
Similar performance was achieved regardless of the 
magnitude of the prescribed CF. Illustrated in Fig. 9, are the 
results for one representative experiment where the CCFC was 
programmed to deliver a CF of three clinically relevant levels 
– 15, 25, and 40 g. Consistently similar force distributions, 
were achieved regardless of the prescribed CF value. Detailed 
performance metrics – averaged over all tested motion profiles 
– are shown in Table I for the three prescribed CF levels.  
E. CCFC – Force-Time Integral 
 For all experiments performed to demonstrate that the 
CCFC could achieve a target FTI, the CCFC successfully 
engaged the catheter with a desired CF until a target FTI was 
reached. The results obtained with each configuration of FTI 
and CF are presented in Table II. A representative experiment 
is illustrated in Fig. 10. The lesion delivery time was within 
480 ± 199 ms of the expected duration. This is indicative of a 
regulated CF profile throughout the delivery, as excessive CF 
would result in short lesion delivery times and low CF levels 
would result in the opposite.  
 
TABLE II 
FORCE-TIME INTEGRAL EXPERIMENTS 
Desired Expected Measured 
FTI 
(gs) 
CF 
(g) 
Duration 
(s) 
FTI 
(gs) 
CF 
(g) 
Duration 
(s) 
500 25 20 500 25.7 ± 3.0 19.49 ± 0.01 
40 12.5 500 40.7 ± 3.5 12.29 ± 0.01 
1000 25 40 1000 25.4 ± 3.1 39.36 ± 0.04 
40 25 999 40.4 ± 3.4 24.71 ± 0.01 
1500 25 60 1500 25.3 ± 3.0 59.27 ± 0.06 
40 37.5 1499 40.4 ± 3.4 36.99 ± 0.22 
 
Fig. 8. Histograms (a)-(c) show the distribution of manual and CCFC-
controlled CF for three unique motion profiles (16,15, and 9 from panel (d), 
respectively). The manual intervention histograms indicate that: (a) majority 
of lesion time was spent barely touching the tissue, (b) significant myocardial 
motion resulting in greatly fluctuation CF, and (c) a precise lesion was 
delivered but the force was not centered at the 25 g target. In each case CCFC-
control brings the mean CF to the target. Histograms of manual (d) and 
CCFC-controlled (e) interventions, represented as grey scale values, show a 
significant difference in CF distribution for all 16 motion profiles.  
Fig. 9. (a) original CF profile (green), while the CCFC was disabled. (b) 
illustrates the generated CF profile while the CCFC was engaged to deliver 15 
g (blue), 25 g (orange) and 40 g (purple). Histogram (c) and grey-scale 
representation (d) illustrate the CF distribution between manual and CCFC 
intervention at various desired CF levels. The motion profile depicted here is 
profile #1 from Fig. 8(d). 
TABLE I 
PATIENT MOTION EXPERIMENTS 
Prescribed CF (g) 15 25 40 
5% Percentile 10.1 ± 1.2 19.7 ± 1.2 34.3 ± 1.2 
95% Percentile 20.6 ± 1.3 31.1 ± 1.5 46.9 ± 1.7 
Mean 15.3 ± 0.1 25.4 ± 0.1 40.4 ± 0.1 
RMSE 3.2 ± 0.6 3.4 ± 0.7 3.9 ± 0.8 
All measurements are presented in grams (g) of force.  Mean and standard 
deviation of all 16 profiles are reported. 
 
Fig. 7. Step response of the CCFC for a reference value of 25 g. At every time 
point, the mean and standard deviation are plotted. 
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With each configuration of desired CF and FTI a similar 
profile was generated with an expected and predicable 
deviation. 
V. DISCUSSION 
We have presented a novel and easy to use tool that 
regulates the CF imparted by standard ablation catheters on 
moving tissue regardless of the type of motion imposed. The 
compact hand-held device is used with commercially available 
force-sensing ablation catheters and steerable sheaths, which 
are widely used in modern electrophysiology suites. The 
presented CCFC utilizes the same tools and information 
available to the interventionalist but grants the ability to 
regulate CF and FTI. 
While contact force measurement (at the tip of an ablation 
catheter) has been available to electrophysiologists for some 
time, it has been used primarily as a visual guide to determine 
if adequate contact has been made or if there is a risk of tissue 
perforation. The CCFC has been demonstrated to control the 
force at the tip of the catheter to within a few grams of a 
prescribed force level. 
The CF profiles, recorded during clinical ablation 
procedures, used to impart clinically relevant motion for 
evaluating the CCFC and shown in Fig. 8 demonstrate some of 
the problems associated with ablation delivery.  For example, 
profile #16 (Fig. 8(a)) represents a lesion where negligible 
force existed between the catheter tip and the wall during most 
of the time RF power was being delivered; when the CCFC 
was engaged the mean CF was increased to 25 g, as 
prescribed. Similarly, the scenario depicted in Fig. 8(b) 
demonstrates large variations in contact force (manual) due to 
motion, which is corrected via the use of the CCFC, reducing 
the RMSE (about 25 g) from 15.1 to 5.5 g. Even when a tight 
distribution of forces is achieved manually, as in Fig. 8(c), the 
mean CF may not be at a level sufficiently high for the 
delivery of a transmural lesion – use of the CCFC in this case 
shifts the distribution of CF from being centered about 15 g to 
being centered about 25 g. Consistently narrow, and 
symmetric, distributions of CF were also achieved for 
different prescribed CF levels (Fig. 9, Table I). 
Successful control of CF over the duration of lesion 
“delivery” also enabled control of FTI. Automatic engagement 
and retraction of the catheter for specified FTI at a desired CF 
has the potential to become a fundamental and powerful tool 
in the electrophysiology suite.  While FTI has been proposed 
as a useful measure in predicting lesion transmurality and 
volume, without a device like the CCFC FTI cannot be easily 
used as a metric clinically or in preclinical studies aimed at 
optimizing lesion delivery parameters.  
The study evaluating the performance of the CCFC under 
conditions of rapidly varying motion have also demonstrated 
that use of the CCFC clinically has potential to minimize 
tissue damage due to excessive force.  The CCFC was able to 
compensate for changes in CF as fast as 700 g/s and maintain 
CF within 15 g of the prescribed values. These results are 
significant because they indicate that using the CCFC, forces 
able to perforate tissue [22] would never be achieved.  
The CCFC was designed as a hand-held device that would 
enable the interventionalist to engage it at any point during a 
complete ablation procedure, but is free to perform all other 
tasks as is done under current clinical practice. The CCFC can 
easily be removed from the catheter/sheath assembly to ensure 
optimal catheter steerability and be re-clamped when a target 
location has been reached, just prior to RF power delivery. 
The device is versatile and can be used as a stand-alone CF 
control aid or can be incorporated with catheter robotic 
navigation systems for further improvements in position and 
force control. Ongoing in vitro and in vivo studies aim to 
demonstrate the full effectiveness of the CCFC in controlling 
lesion volume. 
VI. LIMITATIONS 
Despite the extremely promising results, it is important to 
note that the study is limited by the fact that the motion of an 
in vitro dynamic phantom was used as a surrogate for contact 
force measured at the catheter tip during CCFC evaluation; the 
limitation is manifested in two ways. First, using a strain 
gauge positioned behind tissue-simulating silicone to provide 
CF measurements introduced damping of the CF that would 
have been measured at the tip of the catheter (i.e. at the 
interface of the catheter and silicone). Implementation of the 
CCFC with a force-sensing catheter would require re-tuning of 
the control parameters to account for the different dynamics.  
Second, for the phantom based experiments, the acquired CF 
data were implemented as linear motion profiles with the 
catheter placed perpendicular to the surface of the tissue. This 
experimental design assumed that the catheter was oriented 
the same way during acquisition of the clinical data. If 
clinically, the catheter tip was oriented at an oblique angle, 
larger motion profiles would correspond to the measured 
forces. It is likely however that the true characteristics of 
myocardial tissue motion will contain the same frequency 
components as the profiles used in this study, which ultimately 
does not affect the implemented control system of the CCFC. 
All CF profiles used to evaluate the CCFC were acquired 
from patients undergoing pulmonary vein isolation ablation 
therapy and may not be representative of the CF profiles 
measured during ablation therapies of the left ventricle.  
 
Fig. 10 Interval 0-20 s, the catheter was in contact with the phantom while the 
CCFC was disabled. Interval 20-39.5 s, the CCFC was engaged to deliver 
500 gs at 25 g. Interval 39.5-45 s, the tip of the catheter retracted into the 
sheath once the desired FTI (red) had been reached. The motion profile 
depicted here is profile #15 from Fig. 8(d). 
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During left ventricular ablation procedures CF may change 
more rapidly due to systolic motion. The safety experiments 
performed as part of the present study contained CF 
waveforms with high changes of CF, larger than would be 
expected in ventricular ablations, and these preliminary tests 
provide confidence that the CCFC will be able to control force 
even during ventricular ablations.  
VII. CONCLUSIONS 
This study represents the first demonstration of contact 
force control using a versatile hand-held catheter contact force 
controller, which can be coupled to any force-sensing ablation 
catheter/steerable sheath combination.  The demonstrated 
control of contact force under varying motion conditions is 
promising and suggests that – when implemented in 
combination with a force-sensing catheter – the CCFC can 
deliver prescribed ablation lesions. 
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